Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

155 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.
Nathan SD, Noble PW, Tuder RM. Nathan SD, et al. Among authors: noble pw. Am J Respir Crit Care Med. 2007 May 1;175(9):875-80. doi: 10.1164/rccm.200608-1153CC. Epub 2007 Jan 25. Am J Respir Crit Care Med. 2007. PMID: 17255562 Review.
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.
Nathan SD, Costabel U, Albera C, Behr J, Wuyts WA, Kirchgaessler KU, Stauffer JL, Morgenthien E, Chou W, Limb SL, Noble PW. Nathan SD, et al. Among authors: noble pw. Respir Med. 2019 Jul;153:44-51. doi: 10.1016/j.rmed.2019.04.016. Epub 2019 Apr 24. Respir Med. 2019. PMID: 31153107 Clinical Trial.
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.
Lancaster L, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, King TE Jr, Lederer DJ, Lin Z, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Lancaster L, et al. Among authors: noble pw. BMJ Open Respir Res. 2016 Jan 12;3(1):e000105. doi: 10.1136/bmjresp-2015-000105. eCollection 2016. BMJ Open Respir Res. 2016. PMID: 26835133 Free PMC article.
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.
Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE Jr, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU. Nathan SD, et al. Among authors: noble pw. Thorax. 2016 May;71(5):429-35. doi: 10.1136/thoraxjnl-2015-207011. Epub 2016 Mar 11. Thorax. 2016. PMID: 26968970 Free PMC article. Clinical Trial.
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Espindola MS, Habiel DM, Narayanan R, Jones I, Coelho AL, Murray LA, Jiang D, Noble PW, Hogaboam CM. Espindola MS, et al. Among authors: noble pw. Am J Respir Crit Care Med. 2018 Jun 1;197(11):1443-1456. doi: 10.1164/rccm.201707-1519OC. Am J Respir Crit Care Med. 2018. PMID: 29634284 Free PMC article.
Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute.
Thannickal VJ, Henke CA, Horowitz JC, Noble PW, Roman J, Sime PJ, Zhou Y, Wells RG, White ES, Tschumperlin DJ. Thannickal VJ, et al. Among authors: noble pw. Am J Pathol. 2014 Jun;184(6):1643-51. doi: 10.1016/j.ajpath.2014.02.003. Epub 2014 Apr 13. Am J Pathol. 2014. PMID: 24726499 Free PMC article. Review.
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE Jr, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP. Blackwell TS, et al. Among authors: noble pw. Am J Respir Crit Care Med. 2014 Jan 15;189(2):214-22. doi: 10.1164/rccm.201306-1141WS. Am J Respir Crit Care Med. 2014. PMID: 24160862 Free PMC article.
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis.
Noble PW, Richeldi L, Kaminski N. Noble PW, et al. Am J Respir Crit Care Med. 2011 Jul 1;184(1):4-5. doi: 10.1164/rccm.201105-0813ED. Am J Respir Crit Care Med. 2011. PMID: 21737589 No abstract available.
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr. du Bois RM, et al. Among authors: noble pw. Am J Respir Crit Care Med. 2011 May 1;183(9):1231-7. doi: 10.1164/rccm.201007-1179OC. Epub 2010 Dec 3. Am J Respir Crit Care Med. 2011. PMID: 21131468 Clinical Trial.
Time will tell: predicting survival in idiopathic interstitial pneumonia.
Noble PW, Morris DG. Noble PW, et al. Am J Respir Crit Care Med. 2003 Sep 1;168(5):510-1. doi: 10.1164/rccm.2306021. Am J Respir Crit Care Med. 2003. PMID: 12941653 No abstract available.
155 results
Jump to page
Feedback